NICE approves new oral anti-coagulant for atrial fibrillation
The drug edoxaban has been given the official seal of approval for NHS use in preventing stroke and blood clots in patients with a common heart disorder.
Source: Nursing Times Breaking News - Category: Nursing Source Type: news
More News: Atrial Fibrillation | Cardiology | Heart | National Institute for Health and Clinical Excelle | Nurses | Nursing | Stroke